Chronic rejection

Current Opinion in Nephrology and Hypertension

Volumn 5, Issue 3, 1996, Pages 269-272

  Koskinen, Petri ^a,b   Lemström, Karl ^a   Häyry, Pekka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Transplantation Laboratory   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; AORTA; CAROTID ARTERIES; CHRONIC DISEASE; ENDOTHELIUM, VASCULAR; FORECASTING; GRAFT REJECTION; HISTOLOGICAL TECHNIQUES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; RISK FACTORS;

EID: 0030002558     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199605000-00013     Document Type: Review

References (18)

1. Bia MJ: Nonimmunological causes of late renal graft loss. Kidney Int 1995, 47:1470-1480.
2. Häyry P, Isoniemi H, Yilmaz S, Mennander A, Lemström K, Räisänen-Sokolowski A, Koskinen P, Ustinov J, Lautenschlager I, Taskinen E, et al: Chronic allograft rejection. Immunol Rev 1993, 134;134-181.
3. Fellström B: Immune injury: is it all there is to chronic graft rejection? Nephrol Dial Transplant 1995, 10:149-151.
4. Troppman C, Gillingham KJ, Benedetti E, Almond PS, Gruessner RWG, Najarian JS, Matas AJ: Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995, 59:962-968. A multivariate analysis that evaluates delayed graft function and acute rejection as risk factors for poor allograft outcome.
5. Kuo P, Monaco AP: Chronic rejection as a result of suboptimal immunosuppression. Transplant Proc 1993, 25:2082-2084.
6. Almond PS, Matas A, Gillingham K, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS: Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993, 55:752-757.
7. Isoniemi H, Kyllönen L, Eklund B, Höckerstedt K, Salmela K, von Willebrand E, Ahonen J: Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss. Transplant Proc 1995, 27:875-877.
8. cre.
9. Isoniemi H, Taskinen E, Häyry P: Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994, 58:1195-1198. This study introduces the chronic allograft damage index (CADI). Using protocol core needle biopsies 2 years after transplantation and a follow-up of 6 years it was demonstrated that CADI at 2 years correlated significantly with transplant function at 6 years, and that CADI at 2 years reliably predicted patients who would proceed to clinical chronic rejection later.
10. Lemström K, Koskinen P, Häyry P: Molecular mechanisms of chronic renal allograft rejection. Kidney Int 1995, 48(suppl 52):S2-S10. An up-dated review of molecular mechanisms of chronic renal allograft rejection focusing on cytokines, adhesion molecules and peptide growth factors.
11. Häyry P, Räisänen A, Ustinov J, Mennander A, Paavonen T: Mechanism of lantreotide inhibition of smooth muscle cell replication in allograft arteriosclerosis. FASEB J 1993, 7:1055-1060.
12. Häyry P, Myllärniemi M, Aavik E, Alatalo S, Aho P, Yilmaz S, Räisänen-Sokolowski A, Gozzone G, Jameson BA, Baserga R: Stable D-peptide analogue of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J 1995, 9:1336-1344. This study demonstrates that the IGF-1 receptor gene is one of the major rate-limiting genes in smooth muscle cell replication.
13. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yetman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA, et al.: Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995, 333:621-627.
14. Wahlers T, Mugge A, Oppelt P, Heublein B, Fieguth HG, Jurmann MJ, Uthoff K, Haverich A, Albes JM, Foegh M, Borst HG: Preventive treatment of coronary vasculopathy in heart transplantation by inhibition of smooth muscle cell proliferation with angiopeptin. J Heart Lung Transplant 1995, 14:143-150.
15. Taylor DO, Ensley RD, Olsen SL, Dunn D, Renlund DG: Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation. J Heart Lung Transplant 1995, 13:571-582.
16. Räisänen-Sokolowski A, Aho P, Myllärniemi M, Kallio E, Häyry P: Inhibition of early chronic rejection in rat aortic allografts by mycophenolate mofetil (RS61443). Transplant Proc 1995, 27:435.
17. Azuma H, Binder J, Heemann U, Schmid C, Tullius SG, Tilney NL: Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 1995, 27:460-466.
18. Granger DK, Cromwell JW, Chen SC, Groswitz JJ, Morrow DT, Beierle FA, Sehgal SN, Canafax DM, Matas AJ: Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy. Transplantation 1995, 59:183-186.